Browsing Tag
InnoCare Pharma
3 posts
InnoCare Pharma receives Chinese IND clearance for novel B7-H3 targeted ADC ICP-B794 to treat solid tumors
InnoCare Pharma gains Chinese IND approval for ICP-B794, a novel B7-H3 targeted ADC for solid tumors including lung and prostate cancer.
InnoCare and KeyMed license CD20xCD3 antibody ICP-B02 to Prolium for global development
In a move poised to reshape the landscape of cancer and autoimmune treatments, InnoCare Pharma and KeyMed Biosciences…
InnoCare Pharma, ArriVent BioPharma initiate Phase 1b clinical trial in NSCLC
InnoCare Pharma, listed on both the Hong Kong Stock Exchange (HKEX: 09969) and the Shanghai Stock Exchange (SSE:…